600774.SH
汉商集团
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 7.17
−2.05%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−97.9x
Market Cap
CNY 2.11B
MomentumView details →
1D Return
−2.05%
YTD Return
−15.65%
RSI (14)
62.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−97.9x
Market Cap
CNY 2.11B
RSI (14)
62.0
MomentumView details →
1D Return
−2.05%
YTD Return
−15.65%
Similar companies
Latest newsMore news →
Hangzhou Han Group announced it will cancel 6,024,130 repurchased shares and reduce its registered capital, effective September 2, 2026.4d agoHanshang Group announced its unaudited first-half 2026 results: main business revenue of 461 million yuan, down 10.03% year-on-year, with gross margin of 43.28%, down 3.33 percentage points.6d ago